<DOC>
	<DOCNO>NCT00280384</DOCNO>
	<brief_summary>To evaluate inter-ethnic similarity pharmacodynamics Japanese Caucasian healthy adult male subject compare electrophysiological reaction administer E2014 extensor digitorum brevis muscle ( EDB ) .</brief_summary>
	<brief_title>An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects</brief_title>
	<detailed_description />
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>rimabotulinumtoxinB</mesh_term>
	<criteria>Inclusion criterion : 1 . Participants age 20 44 year time obtain informed consent . 2 . Participants whose M wave amplitude potential ( baseline negative peak ) EDB stimulate peroneal nerve foot joint 1 mV electrophysiological examination time screen immediately administration . 3 . Participants judge eligible study entry investigator subinvestigator screen immediately pretreatment medical examination . 4 . Participants give full explanation objective detail study start screen give write consent base free . 1 . Participants complication history peripheral neuropathy , nerve root impairment , muscle disease . 2 . Participants disease may influence study drug evaluation , disorder gastrointestinal tract , liver , respiratory , endocrine , hematological , neurological , psychiatric cardiovascular system , congenital abnormality metabolism . 3 . Participants accessory deep peroneal nerve . 4 . Participants previously receive treatment botulinum toxin . 5 . Participants history hypersensitivity component E2014 ( human serum albumin , succinate buffer solution ) . 6 . Participants positive urine drug screening time screen immediately study drug administration . 7 . Participants receive prescription drug ( ) within 1 month study drug administration . 8 . Participants treat another investigational drug within 4 month study drug administration . 9 . Participants experience heavy exercise hard labor within 2 week study drug administration . 10 . Participants underwent blood transfusion within 3 month , whose 400 mL whole blood collect within 3 month , whose 200 mL whole blood collect within 1 month study drug administration . 11 . Participants positive hepatitis B surface antigen ( HBs antigen ) , hepatitis C virus ( HCV ) antibody , serologic test syphilis ( STS ) . 12 . Participants receive diagnosis acquire immunodeficiency syndrome ( AIDS ) positive result human immunodeficiency virus . 13 . Participants unwilling unable abide requirement study , may violate prohibition restriction study . 14 . Participants judge ineligible study entry principal investigator subinvestigator .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>